P/E ratio for ICU Medical (ICUI)
P/E ratio as of April 2025 (TTM): -69.0
According to ICU Medical 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -68.9703. At the end of 2022 the company had a P/E ratio of -50.5.
P/E ratio history for ICU Medical from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -50.5 | -203.57% |
| 2021 | 48.7 | -5.71% |
| 2020 | 51.7 | 35.62% |
| 2019 | 38.1 | -76.43% |
| 2018 | 162 | 172.51% |
| 2017 | 59.3 | 57.06% |
| 2016 | 37.8 | -4.86% |
| 2015 | 39.7 | -16.12% |
| 2014 | 47.3 | 104.34% |
| 2013 | 23.2 | 10.27% |
| 2012 | 21.0 | 50.81% |
| 2011 | 13.9 | -15.65% |
| 2010 | 16.5 | -17.96% |
| 2009 | 20.1 | 3.88% |
| 2008 | 19.4 | -12.81% |
| 2007 | 22.2 | -2.74% |
| 2006 | 22.9 | -14.9% |
| 2005 | 26.9 | -63.65% |
| 2004 | 73.9 | 246.94% |
| 2003 | 21.3 | -18.35% |
| 2002 | 26.1 | 2.59% |
| 2001 | 25.4 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 | 143 | -306.75% | 🇺🇸 USA |
 | 53.2 | -177.08% | 🇺🇸 USA |
 | 29.5 | -142.79% | 🇺🇸 USA |
 | 56.9 | -182.55% | 🇺🇸 USA |
 | 15.3 | -122.24% | 🇺🇸 USA |
 | 37.4 | -154.17% | 🇺🇸 USA |
 | 5.62 | -108.15% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.